ARTICLE | Distillery Therapeutics
Inflammation; endocrine/metabolic
August 16, 2018 4:12 PM UTC
In vitro and mouse studies identified a selective SGMS2 inhibitor that could help treat chronic inflammation and Type II diabetes. Chemical synthesis of benzoisoxazole analogs and in vitro enzyme acti...
BCIQ Company Profiles
BCIQ Target Profiles